Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma

The outcomes of patients treated with surgery for early stage pancreatic ductal adenocarcinoma (PDAC) are variable with median survival ranging from 6 months to more than 5 years. This challenge underscores an unmet need for developing personalized medicine strategies to refine the current treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Chen, Dung-Tsa, Davis-Yadley, Ashley H., Huang, Po-Yu, Husain, Kazim, Centeno, Barbara A., Permuth-Wey, Jennifer, Pimiento, Jose M., Malafa, Mokenge
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4527782/
https://ncbi.nlm.nih.gov/pubmed/26247463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0133562
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados